Todd D Levine

Summary

Publications

  1. ncbi request reprint History of dermatomyositis
    Todd D Levine
    Phoenix Neurological Associates and Department of Neurology, University of Arizona, 85006, USA
    Arch Neurol 60:780-2. 2003
  2. pmc Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
    Todd Levine
    Phoenix Neurological Associates, Phoenix, AZ, USA
    Drug Des Devel Ther 6:133-9. 2012
  3. ncbi request reprint Rituximab in the treatment of dermatomyositis: an open-label pilot study
    Todd D Levine
    Phoenix Neurological Associates, Phoenix, Arizona 85006, USA
    Arthritis Rheum 52:601-7. 2005
  4. doi request reprint A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers
    Todd D Levine
    PNA Center for Neurologic Research, 5090 N 40th St, Phoenix, AZ 85018, USA
    Amyotroph Lateral Scler 11:514-9. 2010

Collaborators

Detail Information

Publications4

  1. ncbi request reprint History of dermatomyositis
    Todd D Levine
    Phoenix Neurological Associates and Department of Neurology, University of Arizona, 85006, USA
    Arch Neurol 60:780-2. 2003
  2. pmc Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
    Todd Levine
    Phoenix Neurological Associates, Phoenix, AZ, USA
    Drug Des Devel Ther 6:133-9. 2012
    ....
  3. ncbi request reprint Rituximab in the treatment of dermatomyositis: an open-label pilot study
    Todd D Levine
    Phoenix Neurological Associates, Phoenix, Arizona 85006, USA
    Arthritis Rheum 52:601-7. 2005
    ..Patients were treated with rituximab, a CD20+ B cell-depleting monoclonal antibody...
  4. doi request reprint A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers
    Todd D Levine
    PNA Center for Neurologic Research, 5090 N 40th St, Phoenix, AZ 85018, USA
    Amyotroph Lateral Scler 11:514-9. 2010
    ..Patients receiving memantine and riluzole lost on average -0.73 ALSFRS points per month. Furthermore, levels of CSF tau at baseline could be correlated with how rapidly a patient's disease progressed...